Issue link: http://catalog.e-digitaleditions.com/i/275023
39 Dollar amounts in millions except per share amounts or as otherwise specified Rollforward of Level 3 Pension Plan Assets 2013 2012 Balance at January 1 $ 23 $ 17 Actual return on plan assets held at the reporting date — — Purchases, sales, and settlements (1) 6 Balance at December 31 $ 22 $ 23 We expect to contribute $20 to our defined benefit pension plans in 2014. The estimated future benefit payments by year based on expected future service as appropriate are: 2014 2015 2016 2017 2018 2019-2023 Expected benefit payments $ 16 $ 15 $ 15 $ 15 $ 15 $ 81 NOTE 13 - SEGMENT AND GEOGRAPHIC DATA We segregate our operations into three reportable business segments: Reconstructive, MedSurg, and Neurotechnology and Spine. The Reconstructive segment includes orthopaedic reconstructive (hip and knee) and trauma implant systems as well as other related products. The MedSurg segment includes surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical); and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. The Other category shown in the table below includes corporate and global operations administration, central research and development initiatives, interest expense, interest and marketable securities income and share-based compensation, which includes compensation related to both employee and director stock option, restricted stock unit and performance stock unit grants. Our reportable segments are business units that offer different products and services and are managed separately because each business requires different manufacturing, technology and marketing strategies. The accounting policies of the segments are the same as those described in the summary of significant accounting policies in Note 1 to the Consolidated Financial Statements. We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring and related charges, reserves for certain product recall matters, reserves for certain legal and regulatory matters, a donation to an educational institution, and certain income tax adjustments. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally cash and cash equivalents, marketable securities and property, plant and equipment. Results for our reportable segments are as follows: Reconstructive MedSurg Neurotechnology and Spine Other Total 2013 2012 2011 2013 2012 2011 2013 2012 2011 2013 2012 2011 2013 2012 2011 Net sales $4,004 $3,823 $3,710 $3,359 $3,265 $3,160 $1,658 $1,569 $1,437 $ — $ — $ — $ 9,021 $ 8,657 $ 8,307 Depreciation and amortization 273 271 267 84 85 84 135 122 119 19 8 11 511 486 481 Income taxes (credit) 347 344 375 148 177 165 82 76 63 (115) (110) (106) 462 487 497 Segment net earnings (loss) 970 936 926 621 603 535 283 267 221 (258) (246) (234) 1,616 1,560 1,448 Other (net of income taxes): Less acquisition and integration- related charges (72) (37) (142 ) Less restructuring charges (46) (59) (60 ) Less Rejuvenate and related charges (460) (133) — Less regulatory and legal matters (63) (33) — Less donation (15) — — Add income tax adjustments 46 — 99 Net earnings 1,006 1,298 1,345 Total assets 6,675 3,654 3,758 3,382 2,996 2,358 3,147 2,600 2,245 2,539 3,956 3,785 15,743 13,206 12,146 Capital spending 89 87 119 59 51 56 16 53 27 31 19 24 195 210 226